NIH OTT RSS Feed - Infectious Diseases - Vaccineshttp://www.ott.nih.gov/rss/default.aspxOffice of Technology Transfer (OTT).Copyright 2009 NIH Office of Technology Transfer (OTT). All rights reserved.Live Attenuated RSV Vaccines Based on Codon-Pair Deoptimizationhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25702013-06-06Novel Fusion Proteins for HIV Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25672013-05-30A Novel HIV-1 Entry Inhibitorhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25662013-05-22Parvovirus B19 Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25602013-05-07Antimalarial Inhibitors that Target the Plasmodial Surface Anion Channel (PSAC) Protein and Development of the PSAC Protein as Vaccine Targetshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24882013-04-23HIV-Neutralizing Polypeptides: A Novel Use for Platelet Factor 4 or Its Derivativeshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25472013-04-04Infectious Hepatitis E Virus Genotype 3 Recombinants ? Prospective Vaccine Candidates and Vector Systemhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23292013-03-21Human Antibodies and Fusion Proteins with Potent and Broad HIV-1 Neutralizing Activityhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24822013-03-18Oral Shigellosis Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25282013-02-26Novel Vaccine for Prevention and Treatment of Chlamydia Infectionhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25362013-02-21Live Oral Shigella dysenteriae Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25272013-02-16Improved Bacterial Host for Production of Anthrax Toxin Proteins and Vaccines: Bacillus anthracis BH450http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=15992013-02-15Full-Length cDNA Clone Representing the Consensus Sequence of the RNA Genome of a Human Norovirus (strain MD145-12) That Encodes Biologically Active Proteinshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9032013-02-14Enzymatically-Active RNA-Dependent RNA Polymerase From a Human Norovirus (Calicivirus)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9082013-02-14Construction of an Infectious Full-Length cDNA Clone of the Porcine Enteric Calicivirus RNA Genomehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9092013-02-14Construction of Recombinant Baculoviruses Carrying the Gene Encoding the Major Capsid Protein, VP1, From Calicivirus Strains (Including Norovirus Strains Toronto, Hawaii, Desert Shield, Snow Mountain, and MD145-12)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9102013-02-14Live Attenuated Rubella Vector to Express Vaccine Antigenshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25252013-02-05DNA Promoters and Anthrax Vaccineshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25262013-02-05Multivalent Meningiococcal Conjugates and Methods for Preparing Conjugateshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25162013-01-23Transmission-Blocking Malaria Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25062013-01-11Typhoid-Plague Bivalent Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25092013-01-11Gag-Based DNA Vaccines Against HIV99 of all known Gag sequences elicited strong, cellular T-cell and humoral antibody immune responses. The Gag-specific antibody responses were high titer and cross-clade. Cross-clade protection is important given the sequence diversity of HIV as is the absence of immunodominant epitopes that generate antibodies which are not protective against HIV.]]>http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25032012-11-21Method of Making a Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=18992012-09-28Generation of Wild-Type Dengue Viruses for Use in Rhesus Monkey Infection Studieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=17362012-09-12Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruseshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=20052012-08-31Filovirus Vaccines and Diagnostics Based on Glycoprotein-Fc Fusion Proteinshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23152012-08-17Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin as an Influenza Vaccine10-fold higher than a matched inactivated vaccine. The immune sera raised by HA-ferritin nanoparticles expressing a 1999 HA neutralized seasonal H1N1 viruses from 1934 to 2007 and protected ferrets from an unmatched 2007 H1N1 virus challenge. This extended neutralization coverage is partially explained by the presence of both type of antibodies, antibodies directed to the conserved HA stem and against the RBS region. Finally, this ferritin nanoparticle vaccine platform has significant advantages in the ability to utilize specific multimerized spikes and it may be applicable to other viral proteins.]]>http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24632012-07-20A Broadly Neutralizing Human Anti-HIV Monoclonal Antibody (10E8) Capable of Neutralizing Most HIV-1 Strainshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24282012-05-01Parvovirus B19 Codon Optimized Structural Proteins for Vaccine and Diagnostic Applicationshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=21102012-04-30Diagnostic H5N1 Avian Influenza Virus Peptideshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=21252012-04-30Bacterially Expressed Influenza Virus Recombinant HA Proteins for Vaccine and Diagnostic Applicationshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=21262012-03-03Influenza Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23652012-02-21Method for Producing Significant Amounts of B19 Virus for Development of Killed or Attenuated Vaccineshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=14752012-01-18Immunogenic Tetrasaccharide of Anthrax Sporeshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23482012-01-09New Cholera Vaccine and Method for Conjugating Bacterial Polysaccharides to Proteinshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23492012-01-09Aerosolized Vaccineshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=18282011-11-01Vaccine to Prevent BK Polyomavirus-associated Kidney and Bladder Infections in Organ Transplant Recipientshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23112011-10-24Protease Deficient Bacillus anthracis with Improved Recombinant Protein Yield Capabilitieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23302011-10-21Pertussis Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=22892011-10-11PSM Peptides as Vaccine Targets Against Methicillin-Resistant Staphylococcus aureushttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=17172011-09-01A Vaccine for Shigella sonnei for Both Children and Adultshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=19082011-08-30Method to Create Vaccines for the Prevention of Flavivirus Infections by Targeting Micro-RNAhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=22202011-08-02Multivalent Vaccines for Rabies Virus and Filoviruseshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=22872011-07-26Veterinary Influenza Vaccineshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=17312011-03-21Vaccine for Dengue Virushttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=14782011-02-28Porcine Rotavirus Reassortant Compositionshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=13992011-02-28Nucleotide And Amino Acid Sequences Of The Four Variable Domains Of The Major Outer Membrane Proteins Of Chlamydia Trachomatishttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=1212011-02-28Recombinant DNA Clone Containing a Genomic Fragment of PfHRP-II Gene from Plasmodium falciparumhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=11912011-02-28Plasmodium vivax and Plasmodium knowlesi Duffy Receptorhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=11872011-02-28Transmission-Blocking Vaccine Against Malaria (1)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=11852011-02-28